|
NCT04010253
|
Impact of Bronchial Drainage by the Medical Device Simeox® on Function and Respiratory Symptoms Compared to Manual Autogenous Drainage Physiotherapy in Adult Cystic Fibrosis Patients
|
Complet
|
16 avril 2026
|
|
NCT03895671
|
OPEN LABEL PHASE 2 STUDY ON THE EFFICACY AND TOLERANCE OF A COMBINATION OF PONATINIB AND 5-AZACITIDINE IN CHRONIC MYELOGENOUS LEUKAEMIA IN ACCELERATED PHASE OR IN MYELOID BLAST CRISIS - PONAZA TRIAL
|
Statut inconnu
|
16 avril 2026
|
|
NCT02829190
|
Feasibility Study of Phase-contrast MRI for Flow in the External Carotid Branches Arteries in Normal and Pathological Cases
|
Statut inconnu
|
16 avril 2026
|
|
NCT02154854
|
Effect of Advagraf on Arterial Stiffness and on Vascular Fibrosis Plasma Markers on de Novo Renal Transplant Patients
|
Statut inconnu
|
16 avril 2026
|
|
NCT01958762
|
Screening for Cancers in the Oral CAvity Targeting Tobacco Users in Somme, France
|
En recrutement
|
16 avril 2026
|
|
NCT01779817
|
Assessment of Intellectual, Psychological and Behavioural Developments Between 6 and 9 Years of the Children Born to Hyperthyroid Mothers During Pregnancy
|
Statut inconnu
|
16 avril 2026
|
|
NCT01066689
|
Phase III Study of Impact of Treatment With Rituximab on the Progression of Humoral Acute Rejection After Renal Transplantation.
|
Statut inconnu
|
16 avril 2026
|
|
NCT03905239
|
Impact of a Procalcitonin-based Algorithm on Quality of Management in Patients With Uncomplicated Adhesion-related Small Bowel Obstruction Assessed by Textbook Outcome: a Multicenter Cluster-randomized Open-label Controlled Trial. (ALPROC)
|
En recrutement
|
16 avril 2026
|
|
NCT03569488
|
Validation of the French Version of the Low Anterior Resection Syndrome (LARS) Score for Measuring Bowel Dysfunction After Sphincter-preserving Surgery Among Rectal Cancer Patients
|
Statut inconnu
|
16 avril 2026
|
|
NCT03034122
|
Is Caffeine an Environmental Modifier in Huntington's Disease?
|
Complet
|
16 avril 2026
|
|
NCT02416388
|
Phase II/III Randomized Study to Improve Overall Survival in 18 to 60 Year-old Patients, Comparing Daunorubicin Versus High Dose Idarubicin Induction Regimens, High Dose Versus Intermediate Dose Cytarabine Consolidation Regimens, and Standard Versus Mycophenolate Mofetil Prophylaxis of Graft Versus Host Disease in Allografted Patients in First CR : a Backbone InterGroup-1 Trial
|
En recrutement
|
16 avril 2026
|